Oppenheimer Asset Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Oppenheimer Asset Management’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,425	Closed	-$269K	–	1242
2022 Q1	$269K	Buy	14,425 +3,260	+29%	+$58.7K	﹤0.01%	1049
2021 Q4	$239K	Sell	11,165 -1,653	-13%	-$32.6K	﹤0.01%	1134
2021 Q3	$237K	Buy	+12,818	New	+$258K	﹤0.01%	1102

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Oppenheimer Asset Management's OCDX Position: Q2 2022 in Review

Oppenheimer Asset Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 14,425 shares — an estimated $269K sold.

Oppenheimer Asset Management first reported a position in OCDX in Q3 2021 and held it in 3 quarters. The position peaked at $269K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Oppenheimer Asset Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Oppenheimer Asset Management sold 14,425 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $269K.
Oppenheimer Asset Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q3 2021 and held it in 3 quarters.
Oppenheimer Asset Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $269K in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Oppenheimer Asset Management's 13F filing for Q2 2022, filed 8 Aug 2022.